Overview
Arend Karrenbeld practices in Hoofddorp, Netherlands. Mr. Karrenbeld is rated as a Distinguished expert by MediFind in the treatment of Barrett Esophagus. His top areas of expertise are Barrett Esophagus, Colorectal Polyps, Esophageal Cancer, Endoscopy, and Colonoscopy.
His clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Barrett Esophagus.
Locations
Hoofddorp, NH, Netherlands
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Barrett EsophagusMr. Karrenbeld isDistinguished. Learn about Barrett Esophagus.
- Advanced
- Colorectal PolypsMr. Karrenbeld isAdvanced. Learn about Colorectal Polyps.
- EndoscopyMr. Karrenbeld isAdvanced. Learn about Endoscopy.
- Esophageal CancerMr. Karrenbeld isAdvanced. Learn about Esophageal Cancer.
- Experienced
- ColonoscopyMr. Karrenbeld isExperienced. Learn about Colonoscopy.
- Colorectal CancerMr. Karrenbeld isExperienced. Learn about Colorectal Cancer.
- Intestinal CancerMr. Karrenbeld isExperienced. Learn about Intestinal Cancer.
- Microvillus Inclusion DiseaseMr. Karrenbeld isExperienced. Learn about Microvillus Inclusion Disease.
- Mucolipidosis 3Mr. Karrenbeld isExperienced. Learn about Mucolipidosis 3.
- Mucolipidosis Type 4Mr. Karrenbeld isExperienced. Learn about Mucolipidosis Type 4.